EAU 2014 - Poster: Greater short-term relief of lower urinary tract symptoms in prostate cancer patients treated with degarelix compared to goserelin plus bicalutamide: Results of a pooled analysis

STOCKHOLM, SWEDEN (UroToday.com) - Presented by Malcolm Mason,¹ Pierre Richaud,² Zsolt Bosnyak,³ Anders Malmberg,³ Anders Neijber³ at the 29th Annual European Association of Urology (EAU) Congress - April 11 - 15, 2014 - Stockholmsmässan - Stockholm, Sweden.

¹Cardiff University School of Medicine, Institute of Cancer and Genetics, Cardiff, United Kingdom, ²Department of radiotherapy, Institut Bergonié, Bordeaux, France, ³Global Clinical Research and Development, Ferring Pharmaceuticals, Copenhagen, Denmark